Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-14

FDA Approved: TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application to authorize a fixed-dose combination of trandolapril and verapamil hydrochloride, submitted by Glenmark Pharmaceuti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trandolapril and Verapamil Hydrochloride (trandolapril and verapamil hydrochloride)

Snippet

SUPPL AP for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE (TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE)